Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Sara Tolaney MD, MPH
Sara M. Tolaney MD, MPH Advisory Board
Guru Sonpavde MD
Guru P. Sonpavde MD Advisory Board
Annette Hasenburg Prof., Dr, med
Annette Hasenburg Prof., Dr, med Advisory Board
See All Experts
Published in Oncology

Journal Scan / Research · October 10, 2020

Venetoclax Plus R-CHOP as First-Line Treatment for Patients With Diffuse Large B-Cell Lymphoma

Blood

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Paul Hampel MD

Blood
A Phase II Study of Venetoclax Plus R-CHOP as First-Line Treatment for Patients With Diffuse Large B-Cell Lymphoma
Blood 2020 Sep 21;[EPub Ahead of Print], F Morschhauser, P Feugier, IW Flinn, R Gasiorowski, R Greil, A Illes, NA Johnson, JF Larouche, PJ Lugtenburg, C Patti, GA Salles, M Trneny, S de Vos, F Mir, D Samineni, SY Kim, Y Jiang, E Punnoose, A Sinha, E Clark, N Spielewoy, K Humphrey, A Bazeos, AD Zelenetz

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated